| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1d2135027ccdcf5bbe49c5b629261686
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e1eb622f124420d439f72979dea36294 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-948
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-924
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-95 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5091 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-554
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-34 |
| filingDate |
2001-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a02a2255cfe9572610586336e1ca06c6 |
| publicationDate |
2002-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-02065122-A1 |
| titleOfInvention |
Enzymatic test for the determination of the risk of pathologies related to the presence of sialidase or prolidase activity in women body fluid samples |
| abstract |
The current invention describes a method for the determination of the risk of pathologies related to the presence of sialidase and/or prolidase activity in body vluid samples of women, comprising the following steps in order: a) determination of the levels of sialidase and/or prolidase activity in said sample of body fluid; b) comparison of said levels of sialidase and/or prolidase activity with ranges of prefixed values of said activity; c) calculation of the risk factor. This method resulted particularly efficient in permitting to obtain an accurate and reliable evaluation of the risk of pathologies related to the presence of sialidase and/or prolidase activity in samples of body fluid of women. Consequently, this method gives the physician an efficient tool to decide wether or not to administer a pharmacological therapy. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9080198-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1528396-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7591978-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106319028-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106319028-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2955592-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011092610-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008018074-A1 |
| priorityDate |
2001-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |